Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Florida Cancer Specialists (from Sarah Canon research Institute), Orlando, Florida Tampa General Hospital, Tampa, Florida Moffitt Cancer Center, Tampa, Florida Oklahoma Cancer Specialists and Research Institute, LLC, Tulsa, Oklahoma